Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Vaccine entities : Amyris, inc. save search
AMYRIS AND IMMUNITYBIO COMPLETE JOINT VENTURE FOR NEXT GENERATION COVID-19 RNA VACCINE
Published: 2022-01-03 (Crawled : 13:30) - prnewswire.com
IBRX | $4.815 -12.3% -14.02% 7.9M
|
Manufacturing
|
| O: 1.15%
H: 0.0%
C: 0.0%
AMRS | $0.05 -21.88% -16.36% 47M
|
Process Industries
|
| O: 3.14%
H: 14.14%
C: 5.02%
covid-19 covid vaccine
ImmunityBio Announces Completion of $470 Million Post-merger Financing to Fund Late-stage Cancer Clinical Trials, Phase 3 of COVID T-Cell Universal Boost Vaccine Trial and Provides Update on Bladder Cancer BLA Filing
Published: 2021-12-20 (Crawled : 14:30) - biospace.com/
IBRX | $4.815 -12.3% -14.02% 7.9M
|
Manufacturing
|
| O: 1.53%
H: 1.2%
C: -2.41%
AMRS | $0.05 -21.88% -16.36% 47M
|
Process Industries
|
| O: -2.79%
H: 1.93%
C: -3.72%
als bladder cancer trials trial covid cel clinical trials cancer vaccine phase 3 merge t-cell bladder
Mix-and-Match Vaccine Platform May Boost Immune Response & Duration
Published: 2021-12-03 (Crawled : 06:00) - biospace.com/
AMRS | $0.05 -21.88% -16.36% 47M
|
Process Industries
|
| O: -5.61%
H: 0.0%
C: 0.0%
vaccine platform response
ImmunityBio Expands Vaccine Program to Accelerate Use of “Mix-and-Match” Technologies in Developing and Manufacturing Next-Generation COVID-19 Vaccines
Published: 2021-11-18 (Crawled : 21:00) - biospace.com/
IBRX | $4.815 -12.3% -14.02% 7.9M
|
Manufacturing
|
| O: 0.0%
H: 0.07%
C: -6.31%
AMRS | $0.05 -21.88% -16.36% 47M
|
Process Industries
|
| O: -0.69%
H: 2.92%
C: -0.7%
covid vaccine
Amyris Announces JV Partnership With ImmunityBio For Next Generation COVID-19 RNA Vaccine
Published: 2021-11-08 (Crawled : 13:15) - prnewswire.com
IBRX | $4.815 -12.3% -14.02% 7.9M
|
Manufacturing
|
| O: -1.84%
H: 2.46%
C: -0.23%
AMRS | $0.05 -21.88% -16.36% 47M
|
Process Industries
|
| O: -2.0%
H: 0.49%
C: -8.46%
covid partnership vaccine covid-19
Amyris Achieves Promising In-Vivo Results For Intranasal Delivery Of RNA/NLC Vaccine
Published: 2021-08-20 (Crawled : 12:15) - prnewswire.com
AMRS | $0.05 -21.88% -16.36% 47M
|
Process Industries
|
| O: -0.25%
H: 0.0%
C: 0.0%
results vaccine liver
Amyris Completes First Major License For Leading RNA Vaccine Advancing Technology To Human Trials
Published: 2021-07-01 (Crawled : 12:15) - prnewswire.com
AMRS | $0.05 -21.88% -16.36% 47M
|
Process Industries
|
| O: 1.34%
H: 3.01%
C: 2.41%
vaccine license technology trial
Amyris Announces Positive Pre-Clinical Results For COVID-19 RNA Vaccine Platform With Advantaged Manufacturing, Storage And Distribution Characteristics
Published: 2021-02-22 (Crawled : 15:00) - biospace.com/
AMRS | $0.05 -21.88% -16.36% 47M
|
Process Industries
|
| O: 1.79%
H: 12.61%
C: 1.39%
covid positive results vaccine distribution preclinical pre-clinical
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.